Suchergebnisse - (Subject:"Tocilizumab")

11

Response to : 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study'' by Charles

enthalten in: Annals of the rheumatic diseases | 2023

von Ramiro, S. | Mostard, R. | Landewé, R.

CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1143-1151. - PMID 32719045

12

Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome : results of the CHIC study'

enthalten in: Annals of the rheumatic diseases | 2023

von Charles, P.

CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1143-1151. - PMID 32719045

13

Response to : 'Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19- associated cytokine storm syndrome: results of the CHIC study'' by Calvo-Aranda et al

enthalten in: Annals of the rheumatic diseases | 2023

von Ramiro, S. | Mostard, R. | Landewé, R.

14

Correspondence on 'Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome : results of the CHIC study'

enthalten in: Annals of the rheumatic diseases | 2023

von Calvo-Aranda, E. | Cañamares-Orbis, I. | Novella-Navarro, M. | +4

15

Neither earlier nor late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study

enthalten in: Annals of the rheumatic diseases | 2023

von Moiseev, S. | Avdeev, S. | Tao, E. | +6

CommentOn: Telemed J E Health. 2020 Nov;26(11):1326-1327. - PMID 32552498

16

Response to 'Neither earlier not late tocilizumab improved outcomes in the intensive care unit patients with COVID-19 in a retrospective cohort study' by Moiseev et al

enthalten in: Annals of the rheumatic diseases | 2023

von Ramiro, S. | Landewé, R. | Mostard, R.

CommentOn: Telemed J E Health. 2020 Nov;26(11):1326-1327. - PMID 32552498

17

Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease : data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience

enthalten in: Annals of the rheumatic diseases | 2022

von Khan, A. | Cole, A. | Bhadauria, N. | +7

CommentOn: Ann Rheum Dis. 2020 Jul;79(7):859-866. - PMID 32471903

18

Response to : 'High dosage of Methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to Tocilizumab' by Conticini et al

enthalten in: Annals of the rheumatic diseases | 2022

von Ramiro, S. | Mostard, R. | Landewé, R.

CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1143-1151. - PMID 32719045

19

High dosage of methylprednisolone as a rescue, second-line treatment in COVID-19 patients who failed to respond to tocilizumab

enthalten in: Annals of the rheumatic diseases | 2022

von Conticini, E. | Franchi, F. | Bennett, D. | +6

CommentOn: Ann Rheum Dis. 2020 Sep;79(9):1143-1151. - PMID 32719045

20

COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to : 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry' by Gianfrancesco et al. Compassionate use of tocilizumab in severe COVID-19 with hyperinflammation prior to advent of clinical trials - a real-world district general hospital experience' by Khan et al, 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 global rheumatology alliance physician-reported registry' by Gianfrancesco M et al' by Andreica et al and 'COVID-19 outcomes in patients with systemic autoimmune diseases treated with immunomodulatory drugs' by Ansarin et al

enthalten in: Annals of the rheumatic diseases | 2022

von Gianfrancesco, M. | Hyrich, K. | Yazdany, J. | +2

CommentOn: Ann Rheum Dis. 2020 Jul;79(7):859-866. - PMID 32471903

Filter & Sortierung